Active Ingredient History
Acipimox is a niacin derivative used as a lipid-lowering agent. It reduces triglyceride levels and increases HDL cholesterol. It may have less marked adverse effects than niacin, although it is unclear whether the recommended dose is as effective as standard doses of niacin. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bulimia Nervosa (Phase 2)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 2/Phase 3)
Feeding and Eating Disorders (Phase 2)
Healthy Volunteers (Phase 1)
Heart Failure (Phase 2)
Hypertriglyceridemia (Phase 2)
Insulin Resistance (Phase 2)
Metabolic Syndrome (Phase 2/Phase 3)
Obesity, Abdominal (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue